How we allayed a major pharma΄s concerns about Gx entrants and supported unbiased decision-making in the EU market.
The challenge: Estimating the threat of existing and potential generic…
How we helped a major pharma identify and monitor existing and new Gx EU competitors and settle specific court actions with few of them.
The challenge: Identifying and monitoring current and potential competitors and…
How a large pharma in the EU oncology space gained and used competitive intelligence to craft a defense against threats from generics.
The Challenge: Gaining Competitive Intelligence on upcoming generics…
How a leading global player in the respiratory space worked towards speedier access to Russia and China
The Challenge: Leading multinational Pharma company wants to dive deep into key…
A lesser-known competitive strategy involving authorized generics
Authorized generics (AGs) is a less frequently heard terminology but an…